Krishna G - Search Results

1

Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis.

Regev A, Palmer M, Avigan MI, Dimick-Santos L, Treem WR, Marcinak JF, Seekins D, Krishna G, Anania FA, Freston JW, Lewis JH, Sanyal AJ, Chalasani N. Regev A, et al. Among authors: krishna g. Aliment Pharmacol Ther. 2019 Mar;49(6):702-713. doi: 10.1111/apt.15153. Epub 2019 Feb 13. Aliment Pharmacol Ther. 2019. PMID: 30761572 Free PMC article. Review.

2

Tolerability and safety profile of posaconazole: evaluation of 18 controlled studies in healthy volunteers.

Moton A, Krishna G, Wang Z. Moton A, et al. Among authors: krishna g. J Clin Pharm Ther. 2009 Jun;34(3):301-11. doi: 10.1111/j.1365-2710.2009.01055.x. J Clin Pharm Ther. 2009. PMID: 19646076

3

Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers.

Wang Z, Grasela DM, Krishna G. Wang Z, et al. Among authors: krishna g. Clin Ther. 2007 Jun;29(6):1098-106. doi: 10.1016/j.clinthera.2007.06.015. Clin Ther. 2007. PMID: 17692724 Clinical Trial.

4

Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers.

Krishna G, Moton A, Ma L, Medlock MM, McLeod J. Krishna G, et al. Antimicrob Agents Chemother. 2009 Mar;53(3):958-66. doi: 10.1128/AAC.01034-08. Epub 2008 Dec 15. Antimicrob Agents Chemother. 2009. PMID: 19075045 Free PMC article. Clinical Trial.

5

Effects of oral posaconazole on the pharmacokinetics of sirolimus.

Moton A, Ma L, Krishna G, Martinho M, Seiberling M, McLeod J. Moton A, et al. Among authors: krishna g. Curr Med Res Opin. 2009 Mar;25(3):701-7. doi: 10.1185/03007990802644209. Curr Med Res Opin. 2009. PMID: 19196220 Clinical Trial.

6

Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.

Krishna G, Moton A, Ma L, Savant I, Martinho M, Seiberling M, McLeod J. Krishna G, et al. Clin Ther. 2009 Feb;31(2):286-98. doi: 10.1016/j.clinthera.2009.02.022. Clin Ther. 2009. PMID: 19302901 Clinical Trial.

7

Effects of oral posaconazole on the pharmacokinetics of atazanavir alone and with ritonavir or with efavirenz in healthy adult volunteers.

Krishna G, Moton A, Ma L, Martinho M, Seiberling M, McLeod J. Krishna G, et al. J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):437-44. doi: 10.1097/qai.0b013e3181acb51b. J Acquir Immune Defic Syndr. 2009. PMID: 19623694 Clinical Trial.

8

Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment.

Moton A, Krishna G, Ma L, O'Mara E, Prasad P, McLeod J, Preston RA. Moton A, et al. Among authors: krishna g. Curr Med Res Opin. 2010 Jan;26(1):1-7. doi: 10.1185/03007990903364657. Curr Med Res Opin. 2010. PMID: 19886860

9

Nasogastric administration of garenoxacin as crushed tablets with and without concomitant enteral feeding in healthy subjects.

Krishna G, Noveck R, Vargas R, Grasela D, Wang Z. Krishna G, et al. Drugs R D. 2007;8(1):43-50. doi: 10.2165/00126839-200708010-00004. Drugs R D. 2007. PMID: 17249848 Clinical Trial.

10

The effect of omeprazole on the bioavailability and safety of garenoxacin in healthy volunteers.

Krishna G, Kisicki JC, Olsen S, Grasela DM, Wang Z. Krishna G, et al. J Clin Pharmacol. 2007 May;47(5):628-32. doi: 10.1177/0091270006299136. Epub 2007 Mar 29. J Clin Pharmacol. 2007. PMID: 17395892 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

621 results

Search Page